Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01398839 · ClinicalTrials.gov registry record · Phase 3
Safety Study of the VEGA UV-A System to Treat Ectasia
A Phase 3 study, sponsored by Topcon Medical Systems.
- Terminated
- Registry status
- Phase 3
- Development phase
- 103
- Enrollment target
NCT01398839: Clinical Trial Phase 3 study, sponsored by Topcon Medical Systems.
NCT01398839 is a Phase 3 study that was terminated before completion, run by Topcon Medical Systems. The registered enrollment target is 103 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (87% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01398839, a Phase 3 study, was terminated before completion, sponsored by Topcon Medical Systems.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 103 participants
- Enrollment target
Study Summary
The purpose of this research study is to test the safety, tolerability, and effectiveness of corneal collagen cross-linking (CXL) when used to treat ectasia.
Interventions
- DRUG Riboflavin
- DEVICE VEGA UV-A Illumination System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 103 participants |
| Start Date | 2010-12 |
| Est. Completion | 2012-07 |
| Phase | Phase 3 |
Why NCT01398839 stopped before completion
NCT01398839 is an interventional study that assigns participants to a tested intervention. The registered 103 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (87% lower).
The record links to 0 conditions, and to 2 interventions - of which Riboflavin is the first listed.
NCT01398839 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01398839 about?
NCT01398839 is a clinical study titled "Safety Study of the VEGA UV-A System to Treat Ectasia". The purpose of this research study is to test the safety, tolerability, and effectiveness of corneal collagen cross-linking (CXL) when used to treat ectasia.
What is the current status of trial NCT01398839?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 103 participants. The study started on 2010-12. Estimated completion is 2012-07.
What interventions are being tested in trial NCT01398839?
The interventions under investigation include: Riboflavin (DRUG), VEGA UV-A Illumination System (DEVICE).
Who is sponsoring clinical trial NCT01398839?
This trial is sponsored by Topcon Medical Systems, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01398839's enrollment target sits among peer trials
103 1674th of 2000 higher than 325 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04690348 · 103 participants · Phase 2
Intracavitary Carrier-embedded Cs131 Brachytherapy for Recurrent Brain Metastases: a Randomized Phase II Study
- NCT05282277 · 103 participants · Phase 4
Examining the Effects of Estradiol on Neural and Molecular Response to Reward
- NCT05566769 · 103 participants · NA
Performance and Safety of a Digital Tool for Unsupervised Self-assessment of NMOSD
- NCT05834478 · 103 participants · Phase 3
Non-invasive Vagal Nerve Stimulation in Opioid Use Disorders UH3
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia